Download Diplomate in National Board (DNB) 2017 Dec DVD DVD II Previous Question Papers
DECEMBER 2017
DERMATOLOGY AND VENEREOLOGY
PAPER ? ||
DVD/D/17/O6/II
Time :3 hours
Max. Marks :100
Important instructions
- Attempt all questions in order.
Each question carries 10 marks.
Flead the question carefully and answer to the point neatly and legibly.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space
Answer all the parts of a single question together.
Start the question to a question on a fresh page or leave adequate space between
two answers.
0 Draw tabIe/diagrams/flowcharts wherever appropriate.
Write short notes on:
_L
Physical urticaria under the following headings: 2+3+3+2
a) Classification
b) Dermographism
c) Provocation tests in physical urticaria
d) Management
2. a) Newer agents in management of skin involvement in 3+5+2
systemic sclerosis.
b) Management of interstitial lung disease in scleroderma.
0) Treatment monitoring of interstitial lung disease.
3. a) Chapel Wi|| consensus classification of cutaneous vasculitis 2+3+2+3
b) ANCA associated vasculitis
0) Management of Kawasaki?s disease
d) Investigations in cutaneous vasculitis
4. a) Recent advances in the pathogenesis of Toxic Epidermal 5+5
Necrolysis (TEN)
b) Management of TEN.
5. Palmoplantar Keratoderma under the following headings: 4+3+3
a) Pathogenesis
b) Mutilating keratodermas
c) Pachyonychia congenita
6. a) Infantile hemangiomas 3+3+4
b) Congenital hemangiomas
c) Syndromes associated with vascular malformation
7. a) Tuberculids 3+3+4
b) Immuno-histopathological spectrum in cutaneous
tuberculosis.
0) Drug resistance in cutaneous tuberculosis
P.T.O.
-1-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION
HA I I
www.FirstRanker.com
FINAL EXAM www.FirstRanker.coi?h?T'0NAL BWFWcom
DECEMBER 2017
DERMATOLOGY AND VENEREOLOGY
PAPER ? ||
8. a) Sezary syndrome 2+2+2+2+2
b) Erythrodermic CTCL
c) Folliculotrophic mycosis fungoides
d) Evaluation of a patient with CTCL
e) Treatment of stage I and II disease
9. Porphyrias under the following headings: 5+3+2
a) Heme biosynthetic pathway
b) Congenital erythropoietic porphyria
c) Porphyric cutaneous tarda
10. Differential diagnosis of erythroderma in: 3+2+3+2
a) Neonates
b) Young adults
0) Elderly individual
d) Role of skin biopsy in erythroderma
****************
-2-
POSSESSION/USE OF CELL PHONES OR ANY SUCH ELECTRONIC GADGETS IS NOT PERMITTED INSIDE THE EXAMINATION
H A I I
www.FirstRanker.com
This post was last modified on 17 April 2020